Rothschild Capital Partners’s Theriva Biologics TOVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3	Closed	-$52K	–	63
2016 Q3	$52K	Buy	+3	New	+$52K	0.02%	60